Pure Global AI
SFDA MDS-G-028-V1

MDS-G-028-V1/260503

Guidance on Bundling Criteria for Medical Devices within a Single MDMA Application
Saudi ArabiaSaudi Food and Drug AuthorityRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

MDS-G-028-V1/260503 is the official SFDA identifier for “Guidance on Bundling Criteria for Medical Devices within a Single MDMA Application”. MDS-G-028-V1/260503 is the official identifier SFDA uses for this instrument.

Instrument
MDS-G-028-V1
Full name
MDS-G-028-V1/260503
Category
Registration
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
May 5, 2026
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Guidance on Bundling Criteria for Medical Devices within a Single MDMA Application

Complete official 17-page guidance, version 1.0 dated 3 May 2026; the official SFDA catalogue records publication on 5 May 2026. Preserves medical-device family, system, procedure-pack and IVD grouping criteria, limits, exceptions and definitions. Original page images govern; native text is a marked search layer. Product bundling within an MDMA application does not establish blanket permission to combine separate regulatory changes.

MDS-G-028-V1/260503 is the official identifier SFDA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.